(Q44499796)

3 December 2017

Renoprotective effects of vasopeptidase inhibition in an experimental model of diabetic nephropathy (English)

1 reference

3 December 2017

2

C I Johnston

1 reference

3 December 2017

3

L M Burrell

1 reference

3 December 2017

B J Davis

1

1 reference

3 December 2017

W C Burns

4

1 reference

3 December 2017

E Kubota

5

1 reference

3 December 2017

Z Cao

6

1 reference

3 December 2017

M E Cooper

7

1 reference

3 December 2017

T J Allen

8

1 reference

3 December 2017

28 June 2003

1 reference

3 December 2017

1 reference

3 December 2017

46

1 reference

3 December 2017

7

1 reference

3 December 2017

961-971

1 reference

https://scigraph.springernature.com/pub.10.1007/s00125-003-1121-9

3 December 2017

0 references

cites work

Vascular hypertrophy in experimental diabetes. Role of advanced glycation end products

1 reference

12 December 2020

Antihypertensive and antihypertrophic effects of omapatrilat in SHR

1 reference

12 December 2020

Effects of aminoguanidine in preventing experimental diabetic nephropathy are related to the duration of treatment

1 reference

12 December 2020

A low-sodium diet potentiates the effects of losartan in type 2 diabetes

1 reference

12 December 2020

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

12 December 2020

Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures

1 reference

12 December 2020

Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase by the orally active inhibitor mixanpril: a potential therapeutic approach in hypertension

1 reference

12 December 2020

Short- and long-term effect of angiotensin II receptor blockade in rats with experimental diabetes

1 reference

12 December 2020

Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransforming growth factor-beta antibody in db/db diabetic mice

1 reference

12 December 2020

Antihypertensive therapy in a model combining spontaneous hypertension with diabetes

1 reference

12 December 2020

A new radioimmunoassay for human alpha atrial natriuretic peptide and its physiological validation.

1 reference

12 December 2020

Effects of genetic hypertension on diabetic nephropathy in the rat--functional and structural characteristics

1 reference

12 December 2020

Role of angiotensin II and bradykinin in experimental diabetic nephropathy. Functional and structural studies

1 reference

12 December 2020

Rise in albuminuria and blood pressure in patients who progressed to diabetic nephropathy in the Diabetes Control and Complications Trial

1 reference

12 December 2020

Hypertension and diabetes

1 reference

12 December 2020

Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group

1 reference

12 December 2020

Irbesartan normalises the deficiency in glomerular nephrin expression in a model of diabetes and hypertension

1 reference

12 December 2020

Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats

1 reference

12 December 2020

Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes

1 reference

12 December 2020

Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic (mRen-2)27 rat

1 reference

12 December 2020

Evaluation of renin and angiotensin assays and their clinical application.

1 reference

12 December 2020

Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis.

1 reference

12 December 2020

Modulation of nephrin in the diabetic kidney: association with systemic hypertension and increasing albuminuria

1 reference

12 December 2020

Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension

1 reference

12 December 2020

Protective effects of CGS 30440, a combined angiotensin-converting enzyme inhibitor and neutral endopeptidase inhibitor, in a model of chronic renal failure

1 reference

12 December 2020

Vasopeptidase inhibition affords greater renoprotection than angiotensin-converting enzyme inhibition alone.

1 reference

12 December 2020

Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury

1 reference

12 December 2020

Evolution of tubulointerstitial fibrosis in experimental renal infection and scarring

1 reference

12 December 2020

Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study

1 reference

12 December 2020

Nephrin is specifically located at the slit diaphragm of glomerular podocytes

1 reference

12 December 2020

Enalapril retards glomerular basement membrane thickening and albuminuria in the diabetic rat

1 reference

12 December 2020

A New Method for Continuous Chronic Measurement and Recording of Blood Pressure, Heart Rate and Activity in the Rat Via Radio-telemetry

1 reference

12 December 2020

Reduction of the accumulation of advanced glycation end products by ACE inhibition in experimental diabetic nephropathy

1 reference

12 December 2020

Renal renin-angiotensin system in diabetes: functional, immunohistochemical, and molecular biological correlations

1 reference

12 December 2020

Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs

1 reference

12 December 2020

Glomerular filtration rate in streptozocin-induced diabetic rats. Role of exchangeable sodium, vasoactive hormones, and insulin therapy

1 reference

12 December 2020

Cloning of rat nephrin: expression in developing glomeruli and in proteinuric states

1 reference

12 December 2020

Renal expression of transforming growth factor-β inducible gene-h3 (βig-h3) in normal and diabetic rats11See Editorial by Border and Noble, p. 1390

1 reference

12 December 2020

The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury?

1 reference

12 December 2020

Pathological expression of renin and angiotensin II in the renal tubule after subtotal nephrectomy. Implications for the pathogenesis of tubulointerstitial fibrosis

1 reference

12 December 2020

Localization of angiotensin converting enzyme in rat forebrain and other tissues by in vitro autoradiography using 125I-labelled MK351A

1 reference

12 December 2020

Validation in awake rats of a tail-cuff method for measuring systolic pressure

1 reference

12 December 2020

Beta ig-h3, a transforming growth factor-beta-inducible gene, is overexpressed in atherosclerotic and restenotic human vascular lesions

1 reference

12 December 2020

The enhancement of aminonucleoside nephrosis by the co-administration of protamine

1 reference

12 December 2020

Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus

1 reference

12 December 2020

Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury

1 reference

12 December 2020

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

12 December 2020

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

1 reference

12 December 2020

Vasopeptidase inhibition has potent effects on blood pressure and resistance arteries in stroke-prone spontaneously hypertensive rats.

1 reference

12 December 2020

10.1007/S00125-003-1121-9

Identifiers

DOI

1 reference

3 December 2017

1 reference